IRIS
MUSOLINO, Caterina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.596
EU - Europa 12.621
AS - Asia 6.401
SA - Sud America 2.431
Continente sconosciuto - Info sul continente non disponibili 453
AF - Africa 237
OC - Oceania 16
Totale 35.755
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.118
RU - Federazione Russa 6.242
SG - Singapore 2.793
BR - Brasile 2.096
CN - Cina 1.705
IE - Irlanda 1.509
SE - Svezia 1.268
IT - Italia 1.005
HK - Hong Kong 708
DE - Germania 533
FR - Francia 427
UA - Ucraina 388
VN - Vietnam 363
GB - Regno Unito 309
FI - Finlandia 279
PL - Polonia 243
CA - Canada 193
IN - India 157
AR - Argentina 117
BD - Bangladesh 115
MX - Messico 90
TR - Turchia 74
ZA - Sudafrica 66
ID - Indonesia 63
EC - Ecuador 62
NL - Olanda 62
HU - Ungheria 61
AT - Austria 60
BE - Belgio 59
IQ - Iraq 52
ES - Italia 51
JP - Giappone 47
CO - Colombia 46
IL - Israele 38
PK - Pakistan 37
CR - Costa Rica 36
MA - Marocco 36
UZ - Uzbekistan 34
HN - Honduras 33
KE - Kenya 30
VE - Venezuela 28
TN - Tunisia 25
JM - Giamaica 23
EG - Egitto 21
PY - Paraguay 21
PH - Filippine 20
IR - Iran 19
SC - Seychelles 19
CL - Cile 18
CZ - Repubblica Ceca 17
TT - Trinidad e Tobago 17
AE - Emirati Arabi Uniti 16
BO - Bolivia 16
GT - Guatemala 16
CW - ???statistics.table.value.countryCode.CW??? 15
NI - Nicaragua 15
SA - Arabia Saudita 15
LT - Lituania 14
SV - El Salvador 14
DO - Repubblica Dominicana 13
JO - Giordania 13
AZ - Azerbaigian 12
KR - Corea 12
UY - Uruguay 12
DK - Danimarca 10
GR - Grecia 10
MY - Malesia 10
NP - Nepal 10
OM - Oman 10
PE - Perù 10
AU - Australia 9
KG - Kirghizistan 9
PR - Porto Rico 9
PS - Palestinian Territory 9
RO - Romania 9
BG - Bulgaria 8
CH - Svizzera 8
EE - Estonia 8
LB - Libano 8
NO - Norvegia 8
KZ - Kazakistan 7
SN - Senegal 7
AL - Albania 6
AO - Angola 6
GP - Guadalupe 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
SY - Repubblica araba siriana 6
TH - Thailandia 6
TW - Taiwan 6
CI - Costa d'Avorio 5
DZ - Algeria 5
GE - Georgia 5
SK - Slovacchia (Repubblica Slovacca) 5
ET - Etiopia 4
EU - Europa 4
GY - Guiana 4
PA - Panama 4
RS - Serbia 4
AM - Armenia 3
Totale 35.266
Salva come PNG Salva come JPEG
Città #
Ashburn 2.122
Moscow 1.891
Dublin 1.508
Singapore 1.498
Chandler 1.269
Dallas 1.050
Jacksonville 805
San Jose 799
Nyköping 721
Hong Kong 708
Beijing 589
Council Bluffs 430
Messina 352
The Dalles 343
Princeton 279
Dearborn 271
Los Angeles 259
Medford 257
Lauterbourg 249
Warsaw 219
Des Moines 216
Cambridge 209
Ann Arbor 185
New York 182
São Paulo 180
Boardman 141
Munich 126
Buffalo 120
Santa Clara 107
Ho Chi Minh City 105
Tianjin 86
Hanoi 82
Woodbridge 77
Redondo Beach 73
Frankfurt am Main 71
Wilmington 68
Belo Horizonte 65
Rio de Janeiro 65
Budapest 59
Brussels 57
Guangzhou 57
San Mateo 56
Houston 55
Milan 55
Jinan 51
Vienna 50
Atlanta 48
Brasília 48
North Bergen 47
Chicago 44
Montreal 44
Rome 44
Johannesburg 43
Columbus 42
Tokyo 42
Turku 42
Nanjing 41
Orem 41
Shenyang 41
Brooklyn 40
Chennai 39
Seattle 39
Lancaster 37
Hebei 36
Porto Alegre 34
Helsinki 33
Phoenix 33
Pune 33
San Francisco 33
Shanghai 33
Bremen 32
Denver 32
London 32
Nuremberg 30
San José 30
Toronto 30
Curitiba 29
Hangzhou 28
Quito 28
Tashkent 28
Dong Ket 27
Jakarta 27
Stockholm 27
Amsterdam 26
Nairobi 26
Zhengzhou 26
Secaucus 25
Boston 24
Newark 24
Poplar 23
Strasbourg 23
Palermo 22
Guarulhos 21
Campinas 20
Ningbo 20
Ribeirão Preto 20
Washington 20
Manchester 19
Düsseldorf 18
Haikou 18
Totale 19.929
Salva come PNG Salva come JPEG
Nome #
Altered Microrna Expression Profile in the peripheral Lymphomonocytes of Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw 314
EVALUATION OF THROMBIN GENERATION POTENTIAL IN POLYCYTHEMIA VERA PATIENTS ENROLLED IN THE CYTO–PV ITALIAN CLINICAL TRIAL 297
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 271
A multivariate analysis of Multiple Myeloma subtype plasma cells 260
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 254
A micro-Raman spectroscopic investigation of leukemic U-937 cells in aged cultures 251
Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 249
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura 226
Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws 224
Challenge test to bisphosphonates in patients with hypersensitivity reactions to drugs. 219
E rosette formation in B cell chronic lymphocytic leukemia. 215
Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies 214
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 214
Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells 213
Absence of the V617F JAK2 Mutation in the Lymphoid Compartment in a Patient with Essential Thrombocythemia and B-Chronic Lymphocytic Leukemia and in Two Relatives with Lymphoproliferative Disorders 210
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways 208
Comportamento di alcuni indici della fibrinolisi in dislipidemici in corso di trattamento con sinfibrato" 207
A rare spinal localization of gray zone lymphoma without mediastinal involvement: A case report and review of literature 205
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). 204
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 203
Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma 203
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors 199
Aggregazione piastrinica in dislipidemici in corso di trattamento con simfibrato 199
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies 199
Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient. 199
Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. 198
Cerebral venous sinus thrombosis (CVST) associated with SARS-CoV-2 vaccines: clues for an immunopathogenesis common to CVST observed in COVID-19 195
Efficacia della chemioterapia convenzionale ad alte dosi in un caso di mieloma multiplo IgM primitivamente doppio-refrattario ai nuovi farmaci 193
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and n two relatives with lymphoproliferative disorders 192
ASSETTO EMATOLOGICO DI UN GRUPPO DI SOGGETTIAFFETTI DA MORBO DI COOLEY:STUDIO DEL COMPORTAMENTO DELL'ERITROPOIETINA PLASMATICA 192
Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines 191
Anxiety, Depression, Distress, and Resilience in Patients with Haematological Malignancies. The Effect of Nine Weeks of Psychological Support on Psychological Status and Stress Biological Markers 191
Changes in serum interleukin-8 and sRAGE levels in multiple myeloma patients 188
Risk stratification and early cardiotoxicity identification: organizational advantages and clinical impact of intrahospital cardiotoxicity network 188
Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia. 186
Curcumin Ameliorates the In Vitro Efficacy of Carfilzomib in Human Multiple Myeloma U266 Cells Targeting p53 and NF-κB Pathways. 186
Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw. 186
Avascular Necrosis of Bone in Leukemia and Osteonecrosis of Jaw by Bisphosphonates 185
Vaccination of multiple myeloma: Current strategies and future prospects 185
Cutaneous adverse reactions to lenalidomide. 184
L'ipersplenismo: attualità e prospettive future 183
ABERRANT EXPRESSION OF CANCER TESTIS ANTIGENS IN HEMATOLOGIC MALIGNANCIES 180
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma 180
Angiogenesis in patients with biphosphonate-associated osteonecrosis of the jaw 178
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 178
Beta 2 microglobulina ed emopatie maligne 176
Telomerase and telomere biology in hematological diseases: A new therapeutic target 176
Assenza della mutazione JAK2 V617F nel compartimento linfoide di un paziente affetto da trombocitemia essenziale e leucemia linfatica cronica a cellule B ed in due parenti affetti da disordini linfoproliferativi 174
Cancer and sars-cov-2 infection: Diagnostic and therapeutic challenges 171
Phage-AgNPs complex as SERS probe for U937 cell identification 170
A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients 170
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 169
Global cardiovascular assessment in patients with PH+ chronic myeloid leukaemia treated with TKI: long-term follow-up 169
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 168
[Calcium and endocrine pancreas secretion. II. Effects of an infusion of calcium on insulin and glucagon secretion induced by intravenous administration of glucose]. 168
The cancer stem cell hypothesis: a guide to potential molecular targets. 167
Circulating endothelial progenitor cells and angiogenic serum factors in patients with chronic myeloproliferative diseases 167
Serum levels of interleukin-16 in lymphoid malignancies. 167
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 167
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 167
Low-energy laser irradiation promotes cellular damage in glucocorticoid-resistant multiple myeloma cells. 166
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 165
ARA-C a basse dosi nelle sindrome mielodisplastiche in differenti stati evolutivi 164
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 164
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab. 164
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 163
MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma 163
Allergy and risk of hematologic malignancies: Associations and mechanisms. 163
Vaccination strategies in lymphoproliferative disorders: Failures and successes 163
Anticancer activity of rosmarinus officinalis L.: Mechanisms of action and therapeutic potentials 163
Carbonyl groups serum levels are associated with CD38 expression in patients with B chronic lymphocytic leucemia. 162
Standardisation of minimal residual disease in multiple myeloma 161
Immunohistochemical evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw. 158
Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients. 158
Possible role of Interleuki-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity 156
The metabolomic signature of hematologic malignancies 155
FITC-labelled clone from phage display for direct detection of leukemia cells in blood 155
Antiproliferative effects of st. John’s wort, its derivatives, and other hypericum species in hematologic malignancies 155
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. 154
Antitumorigenic action of nelfinavir: Effects on multiple myeloma and hematologic malignancies (Review) 153
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies 153
Decreased plasma levels of IL-33 could contribute to the altered function of Th2 Iymphocytes in patients with poIycythemia vera and essential thrombocythemia. 152
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 152
Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia 150
How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma 150
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. 149
Role of the microbiota in hematologic malignancies. 149
Cardiac involvement in patients with hematologic malignancies. 148
DIFFERENT DAILY BLOOD GLUCOSE CONTROL AND FREE INSULIN LEVELS DURING TREATMENT WITH MIXTURES OF SOLUBLE AND LENTE OR SOLUBLE AND NPH SEMISYNTHETIC HUMAN INSULINS. 144
Castleman–Kojima disease (TAFRO syndrome) in a Caucasian patient: A rare case report and review of the literature 144
Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients 144
Oxidative stress in oncohematologic diseases: an update. 143
Effetti di uno stress fisico sulla funzione pistrinica e su alcuni parametri emocoagulativi e della fibrinolisi 142
Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells 142
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy. 141
Immunohistochemical evaluation of sarcoglycans and integrin in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 140
Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock 139
SERUM LEVELS OF 2', 5 OLIGOADENYLATE SYNTHETASE DURING INTERFERON THERAPY IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC- LEUKEMIA 138
The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention 138
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study 135
Totale 18.040
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.238
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.238
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.403 0 0 0 0 54 23 101 65 54 225 222 659
2022/20234.566 407 387 214 409 312 464 52 231 1.852 27 146 65
2023/20241.079 99 197 70 84 98 244 26 70 11 26 15 139
2024/20255.511 136 85 98 336 302 142 90 1.242 1.476 313 462 829
2025/202615.426 696 1.025 1.186 1.081 1.328 3.249 1.880 1.828 1.856 600 252 445
2026/20273.033 401 574 837 1.000 221 0 0 0 0 0 0 0
Totale 35.755